David J. Bill

2.6k citations

14 papers · 2.2k indexed · 2 hit papers · h-index 10

Impact in

Behavioral Neuroscience top 1%
- Stress Responses and Cortisol
Cellular and Molecular Neuroscience top 1%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research

Papers in

Behavioral Neuroscience 3
- Stress Responses and Cortisol 3
Cellular and Molecular Neuroscience 8
- Neurotransmitter Receptor Influence on Behavior 7
- Neuroscience and Neuropharmacology Research 3

Co-authors: Allan Fletcher Colin T. Dourish Savraj Grewal Deborah E. Jones Ian A. Cliffe Jon K. Shepherd Martha Knight Kelly J. Stanhope
Journals: British Journal of Pharmacology (6 papers)European Journal of Pharmacology (3 papers)Psychopharmacology (3 papers)Behavioural Brain Research (1 paper)CNS Drug Reviews (1 paper)
Partner nations: United Kingdom Ireland France

In The Last Decade

David J. Bill

14 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635 1995 · 550 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1995 European Journal of Pharmacology
1994 Psychopharmacology

Peers

Countries citing papers authored by David J. Bill

Since Specialization

Citations

This map shows the geographic impact of David J. Bill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Bill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Bill more than expected).

Fields of papers citing papers by David J. Bill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Bill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Bill. The network helps show where David J. Bill may publish in the future.

Co-authors

The 25 scholars most cited alongside David J. Bill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David J. Bill Line = papers co-authored together David J. Bill links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats Psychopharmacology ·Savraj Grewal, Joshua Shepherd, David J. Bill, Allan Fletcher, Colin T. Dourish	1997	75
2	Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory Psychopharmacology ·Jonathan Shepherd, David J. Bill, Colin T. Dourish, Savraj Grewal, David Taylor-Robinson, Kelly J. Stanhope	1996	29
3	WAY‐SEC‐579: A Novel 5‐HT₃ Receptor Antagonist CNS Drug Reviews ·Vicki C. Middlefell, David J. Bill, DENISE OLIVE, James L. Coleman, Allan Fletcher, Ian C. Hallett, Y Sudrajat, Adella Rianty, Gloria C. Ugwu	1996	3
4	A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635 European Journal of Pharmacology ·Leann Ness, Ian A. Cliffe, David J. Bill, Koelina Sil, Deborah E. Jones, D. J. Fares, Allan Fletcher Hit paper breakdown →	1995	550
5	The enantiomers of zacopride: an intra‐species comparison of their potencies in functional and anxiolytic models British Journal of Pharmacology ·David J. Bill, James L. Coleman, Ian C. Hallett, Vicki C. Middlefell, Y Sudrajat, Allan Fletcher	1995	4
6	Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist Behavioural Brain Research ·Allan Fletcher, Leann Ness, David J. Bill, Geraldine Brown, Ian A. Cliffe, A Grizic, Deborah E. Jones, David Taylor-Robinson, Kelly J. Stanhope, David Critchley, S. Siggia, Vicki C. Middlefell, Laurence Lanfumey, Renato Corradetti, Anne‐Marie Laporte, H. Gozlan, Michel Hamon, Colin T. Dourish	1995	473
7	Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety Psychopharmacology ·Jon K. Shepherd, Savraj Grewal, Allan Fletcher, David J. Bill, Colin T. Dourish Hit paper breakdown →	1994	594
8	PHARMACOLOGICAL EVALUATION OF THE ELEVATED ZERO-MAZE AS A MODEL OF ANXIETY IN RATS British Journal of Pharmacology ·Joshua Shepherd, Savraj Grewal, Allan Fletcher, David J. Bill, Colin T. Dourish	1993	2
9	WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors European Journal of Pharmacology ·Allan Fletcher, David J. Bill, J. R. Pepin, Ian A. Cliffe, Koelina Sil, Leann Ness, J. Thomas Haskins, Deborah E. Jones, Howard L. Mansell, D. J. Fares	1993	198
10	Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety European Journal of Pharmacology ·David J. Bill, Allan Fletcher, Nur Afeqah Abdullah, Martin Knight	1992	38
11	Direct evidence for an important species difference in the mechanism of 8‐OH‐DPAT‐induced hypothermia British Journal of Pharmacology ·David J. Bill, Martha Knight, Leann Ness, K. K. Hii	1991	155
12	The thermogenic actions of α₂‐adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic α₂‐adrenoceptor mechanism British Journal of Pharmacology ·David J. Bill, I E Hughes, Robert J. Stephens	1989	27
13	The effects of acute and chronic desipramine on the thermogenic and hypoactivity responses to α₂‐agonists in reserpinized and normal mice British Journal of Pharmacology ·David J. Bill, I E Hughes, Robert J. Stephens	1989	9
14	The antinociceptive activity of meptazinol depends on both opiate and cholinergic mechanisms British Journal of Pharmacology ·David J. Bill, 曾信耀, Shiro Toyoshima, Angela Thompson	1983	35

About David J. Bill

David J. Bill is a scholar working on Behavioral Neuroscience, Cellular and Molecular Neuroscience, Animal Science and Zoology, Social Psychology and Molecular Biology, having authored 14 papers that have together received 2.2k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (7 papers), Receptor Mechanisms and Signaling (6 papers), Stress Responses and Cortisol (3 papers), Neuroendocrine regulation and behavior (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Pain Mechanisms and Treatments (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Behavioral Neuroscience (346 citations), Cellular and Molecular Neuroscience (1.5k citations), Biological Psychiatry (121 citations), Social Psychology (471 citations) and Endocrine and Autonomic Systems (134 citations). David J. Bill has collaborated with scholars based in United Kingdom, Ireland and France. Frequent co-authors include Allan Fletcher, Colin T. Dourish, Savraj Grewal, Deborah E. Jones, Ian A. Cliffe, Jon K. Shepherd, Martha Knight, Kelly J. Stanhope, Vicki C. Middlefell and Laurence Lanfumey. Their work appears in journals such as British Journal of Pharmacology, European Journal of Pharmacology, Psychopharmacology, Behavioural Brain Research and CNS Drug Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact